Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

A new US study has added to the evidence that obesity is a risk factor for severe COVID-19. And in this paper, a particular finding has caught the media’s attention: the apparently greater risk posed by COVID-19 to men with obesity than women. But while it’s tempting to take this information at face value, there are several reasons not to.

There are lots of different ways to look at whether and how obesity increases the risk of COVID-19. Body mass index, or BMI, is the main measure used in studies investigating whether people with obesity have worse outcomes. You can easily calculate your BMI online if you know your weight and height.

The association between worse COVID-19 outcomes and obesity was recognised early on in the pandemic. The first large study investigating this relationship was released in July 2020 and used data from more than 17 million adults in England. It showed that having a BMI of over 40 – classified as “severe obesity” – almost doubled a person’s risk of dying from COVID-19. However, it didn’t provide data on people with BMIs in the lower “overweight” or “obese” ranges.

Read the full article on The Conversation website, written by Jamie Hartmann-Boyce (Nuffield Department of Primary Care Health Sciences).

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.